Please assess the completion status of the following clinical trial:

Trial Title: Low Level Laser Therapy With Physical Therapy for Chronic Musculoskeletal Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18-80 years old~2. Primary referral and acceptance to the UTSW McDermott Multidisciplinary Pain Management Program. All diagnoses will be included.~3. Physical therapy specific inclusion for acceptance to the pain program (and this study) include:~   1. Musculoskeletal pain greater than 3 months~  2. Pain upon palpation or with movement of the extremities~  3. Medically cleared for physical therapy (exercise) in terms of cardiac, orthopedic, neurological impairments.~4. Cognitive, verbal, and physical abilities to self-detect and report pain and changes in exercise effort.~5. Ability to speak English and follow exercise based instructions.~6. Able to give informed consent.~Exclusion Criteria:~1. Inability to meet inclusion criteria for pain program~2. Current use of photosensitive medication (has been instructed to minimize sun exposure)~3. Active metastasis~4. Active infection~5. Diagnoses that exclude PT including cauda equine syndrome, myopathy, acute fracture (8-weeks).~6. Impaired sensation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Sham low level laser (Type: SHAM_COMPARATOR): Treatment will be administered 2x/w x 4 weeks as a standalone, then 2 times/week x 4 weeks in conjunction with standard physical therapy and counseling. The clinician will apply 10 minutes of low level laser therapy at a dosage of 0 watts for a total of 0 joules based on body surface area treated. Application will be with light to moderate contact pressure based on patient tolerance (should be no additional discomfort from laser). Area for administration will include 6 minutes of application along spine (C2-S1), and 4 minutes of application either to bilateral upper extremity or bilateral lower extremity based on areas of primary pain complaint. The contact head applicator will be used if soft tissue contact is tolerable. Otherwise, the non-contact head will be utilized.
- Active low level laser (Type: ACTIVE_COMPARATOR): Treatment will be administered 2x/w x 4 weeks as a standalone, then 2 times/week x 4 weeks in conjunction with standard physical therapy and counseling. The clinician will apply 10 minutes of low level laser therapy at a dosage of 15-25 watts for a total of 9,000-15,000 joules based on body surface area treated. This equates to standard acceptable dosing of 6-10 j/cm2 over the larger area of treatment. Application will be with light to moderate contact pressure based on patient tolerance (should be no additional discomfort from laser). Areas for administration and contact will otherwise be consistent with the sham group.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: safety issues